Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS-3150) and sodium-glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase III studies.
Shikata K, Ito S, Kashihara N, Nangaku M, Wada T, Okuda Y, Sawanobori T, Sugimoto K. Shikata K, et al. Among authors: sawanobori t. J Diabetes Investig. 2022 Jul;13(7):1190-1202. doi: 10.1111/jdi.13778. Epub 2022 Apr 21. J Diabetes Investig. 2022. PMID: 35199478 Free PMC article. Clinical Trial.
Predictive Value of CHADS2, CHA2DS2-VASc and R2-CHADS2 Scores for Short- and Long-Term Major Adverse Cardiac Events in Non-ST-Segment Elevation Myocardial Infarction.
Horikoshi T, Nakamura T, Yoshizaki T, Nakamura J, Uematsu M, Kobayashi T, Saito Y, Obata JE, Sawanobori T, Takano H, Umetani K, Asakawa T, Sato A. Horikoshi T, et al. Among authors: sawanobori t. Circ J. 2023 Dec 15. doi: 10.1253/circj.CJ-23-0733. Online ahead of print. Circ J. 2023. PMID: 38104976 Free article.
Optimal medical therapy after percutaneous coronary intervention in very elderly patients with coronary artery disease.
Nakamura T, Horikoshi T, Kobayahi T, Yoshizaki T, Uematsu M, Watanabe Y, Nakamura J, Makino A, Saito Y, Obata JE, Sawanobori T, Takano H, Umetani K, Watanabe A, Asakawa T, Sato A. Nakamura T, et al. Among authors: sawanobori t. Int J Cardiol Cardiovasc Risk Prev. 2022 Nov 30;16:200162. doi: 10.1016/j.ijcrp.2022.200162. eCollection 2023 Mar. Int J Cardiol Cardiovasc Risk Prev. 2022. PMID: 36506909 Free PMC article.
Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation.
Kanaoka K, Onoue K, Terasaki S, Nakano T, Nakai M, Sumita Y, Hatakeyama K, Terasaki F, Kawakami R, Iwanaga Y, Miyamoto Y, Saito Y; Japanese Registry of Fulminant Myocarditis Investigators. Kanaoka K, et al. Circulation. 2022 Nov 8;146(19):1425-1433. doi: 10.1161/CIRCULATIONAHA.121.058869. Epub 2022 Sep 27. Circulation. 2022. PMID: 36164974
A Stratified Analysis of the Risk Associated With Low Body Mass Index for Patients After Percutaneous Coronary Intervention.
Horikoshi T, Nakamura T, Yoshizaki T, Nakamura J, Watanabe Y, Uematsu M, Makino A, Kobayashi T, Saito Y, Obata JE, Sawanobori T, Takano H, Umetani K, Watanabe A, Asakawa T, Sato A. Horikoshi T, et al. Among authors: sawanobori t. J Atheroscler Thromb. 2023 May 1;30(5):502-514. doi: 10.5551/jat.63650. Epub 2022 Jun 25. J Atheroscler Thromb. 2023. PMID: 35753778 Free PMC article.
123 results